maaf email atau password anda salah

Other Tempo Media
Majalah Tempo
Koran Tempo
Tempo.co
Subscribe

Saving Indofarma

Monday, June 3, 2024

The management of Indofarma is designing a plan to rescue the company. Waiting for projects from the government.

arsip tempo : 173484423972.

The pharmaceutical factory of Indofarma in Cibitung, Bekasi, West Java. TEMPO Doc./Stringer/Dasril Roszandi . tempo : 173484423972.

WITH its business in limbo, Indofarma is now waiting for a savior. After being hit by financial problems, from business losses to allegations of misconduct, Indofarma finds itself chased to resolve many obligations. Indofarma Chief Executive Officer (CEO), Yeliandriani, told Tempo on Tuesday, May 28, that the company is facing a case of postponement of debt payment obligations or PKPU filed by creditors. “Currently we are focused on re

...

Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 54.945/Month

Active for 12 Months, Rp 659.340

  • *You Save -Rp 102.000
  • *Guaranteed update of up to 52 Editions of Tempo Magazine
Subscribe

Rp 64.380/Month

Active Every Month Cancel Anytime

  • *Free for the first month if using a Credit Card
Subscribe

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.

Ghoida Rahmah

Caesar Akbar contributed to this article.
Indofarma Bank Loans Commercial Court Pharmaceutical Industry Bio Farma
Prev Next

More Articles

More exclusive contents

  • December 16, 2024

  • December 9, 2024

  • December 2, 2024

  • November 25, 2024

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe